409 related articles for article (PubMed ID: 37205426)
1. Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis.
Yarmolinsky J; Robinson JW; Mariosa D; Karhunen V; Huang J; Dimou N; Murphy N; Burrows K; Bouras E; Smith-Byrne K; Lewis SJ; Galesloot TE; Kiemeney LA; Vermeulen S; Martin P; Albanes D; Hou L; Newcomb PA; White E; Wolk A; Wu AH; Marchand LL; Phipps AI; Buchanan DD; ; Zhao SS; Gill D; Chanock SJ; Purdue MP; Smith GD; Brennan P; Herzig KH; Jarvelin MR; Dehghan A; Johansson M; Gunter MJ; Tsilidis KK; Martin RM
medRxiv; 2023 May; ():. PubMed ID: 37205426
[TBL] [Abstract][Full Text] [Related]
2. Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis.
Yarmolinsky J; Robinson JW; Mariosa D; Karhunen V; Huang J; Dimou N; Murphy N; Burrows K; Bouras E; Smith-Byrne K; Lewis SJ; Galesloot TE; Kiemeney LA; Vermeulen S; Martin P; Albanes D; Hou L; Newcomb PA; White E; Wolk A; Wu AH; Le Marchand L; Phipps AI; Buchanan DD; ; ; Zhao SS; Gill D; Chanock SJ; Purdue MP; Davey Smith G; Brennan P; Herzig KH; Järvelin MR; Amos CI; Hung RJ; Dehghan A; Johansson M; Gunter MJ; Tsilidis KK; Martin RM
EBioMedicine; 2024 Feb; 100():104991. PubMed ID: 38301482
[TBL] [Abstract][Full Text] [Related]
3. Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis.
Yarmolinsky J; Bouras E; Constantinescu A; Burrows K; Bull CJ; Vincent EE; Martin RM; Dimopoulou O; Lewis SJ; Moreno V; Vujkovic M; Chang KM; Voight BF; Tsao PS; Gunter MJ; Hampe J; Pellatt AJ; Pharoah PDP; Schoen RE; Gallinger S; Jenkins MA; Pai RK; ; ; Gill D; Tsilidis KK
Diabetologia; 2023 Aug; 66(8):1481-1500. PubMed ID: 37171501
[TBL] [Abstract][Full Text] [Related]
4. Appraising the role of previously reported risk factors in epithelial ovarian cancer risk: A Mendelian randomization analysis.
Yarmolinsky J; Relton CL; Lophatananon A; Muir K; Menon U; Gentry-Maharaj A; Walther A; Zheng J; Fasching P; Zheng W; Yin Ling W; Park SK; Kim BG; Choi JY; Park B; Davey Smith G; Martin RM; Lewis SJ
PLoS Med; 2019 Aug; 16(8):e1002893. PubMed ID: 31390370
[TBL] [Abstract][Full Text] [Related]
5. Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis.
Yarmolinsky J; Díez-Obrero V; Richardson TG; Pigeyre M; Sjaarda J; Paré G; Walker VM; Vincent EE; Tan VY; Obón-Santacana M; Albanes D; Hampe J; Gsur A; Hampel H; Pai RK; Jenkins M; Gallinger S; Casey G; Zheng W; Amos CI; ; ; ; Smith GD; Martin RM; Moreno V
PLoS Med; 2022 Feb; 19(2):e1003897. PubMed ID: 35113855
[TBL] [Abstract][Full Text] [Related]
6. Potential therapeutic targets for membranous nephropathy: proteome-wide Mendelian randomization and colocalization analysis.
Su Z; Wan Q
Front Immunol; 2024; 15():1342912. PubMed ID: 38707900
[TBL] [Abstract][Full Text] [Related]
7. Mendelian randomisation analysis of circulating adipokines and C-reactive protein on breast cancer risk.
Robinson T; Martin RM; Yarmolinsky J
Int J Cancer; 2020 Sep; 147(6):1597-1603. PubMed ID: 32134113
[TBL] [Abstract][Full Text] [Related]
8. Circulating inflammatory cytokines and risk of five cancers: a Mendelian randomization analysis.
Bouras E; Karhunen V; Gill D; Huang J; Haycock PC; Gunter MJ; Johansson M; Brennan P; Key T; Lewis SJ; Martin RM; Murphy N; Platz EA; Travis R; Yarmolinsky J; Zuber V; Martin P; Katsoulis M; Freisling H; Nøst TH; Schulze MB; Dossus L; Hung RJ; Amos CI; Ahola-Olli A; Palaniswamy S; Männikkö M; Auvinen J; Herzig KH; Keinänen-Kiukaanniemi S; Lehtimäki T; Salomaa V; Raitakari O; Salmi M; Jalkanen S; ; Jarvelin MR; Dehghan A; Tsilidis KK
BMC Med; 2022 Jan; 20(1):3. PubMed ID: 35012533
[TBL] [Abstract][Full Text] [Related]
9. Potential drug targets for multiple sclerosis identified through Mendelian randomization analysis.
Lin J; Zhou J; Xu Y
Brain; 2023 Aug; 146(8):3364-3372. PubMed ID: 36864689
[TBL] [Abstract][Full Text] [Related]
10. Assessing the causal role of epigenetic clocks in the development of multiple cancers: a Mendelian randomization study.
Morales Berstein F; McCartney DL; Lu AT; Tsilidis KK; Bouras E; Haycock P; Burrows K; Phipps AI; Buchanan DD; Cheng I; ; Martin RM; Davey Smith G; Relton CL; Horvath S; Marioni RE; Richardson TG; Richmond RC
Elife; 2022 Mar; 11():. PubMed ID: 35346416
[TBL] [Abstract][Full Text] [Related]
11. Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation study.
Fang S; Yarmolinsky J; Gill D; Bull CJ; Perks CM; ; Davey Smith G; Gaunt TR; Richardson TG
PLoS Med; 2023 Jan; 20(1):e1003988. PubMed ID: 36595504
[TBL] [Abstract][Full Text] [Related]
12. Association Between Genetically Proxied Inhibition of HMG-CoA Reductase and Epithelial Ovarian Cancer.
Yarmolinsky J; Bull CJ; Vincent EE; Robinson J; Walther A; Smith GD; Lewis SJ; Relton CL; Martin RM
JAMA; 2020 Feb; 323(7):646-655. PubMed ID: 32068819
[TBL] [Abstract][Full Text] [Related]
13. Association between circulating vitamin E and ten common cancers: evidence from large-scale Mendelian randomization analysis and a longitudinal cohort study.
Xin J; Jiang X; Ben S; Yuan Q; Su L; Zhang Z; Christiani DC; Du M; Wang M
BMC Med; 2022 May; 20(1):168. PubMed ID: 35538486
[TBL] [Abstract][Full Text] [Related]
14. Causal relationship between inflammatory factors and cerebral small vessel disease: Univariate, multivariate, and summary-data-based mendelian randomization analysis.
Qiao TC; Tian HY; Shan SZ; Shan LL; Peng ZY; Ke J; Li MT; Wu Y; Han Y
Brain Behav; 2024 Feb; 14(2):e3399. PubMed ID: 38340139
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide association study meta-analysis identifies three novel loci for circulating anti-Müllerian hormone levels in women.
Verdiesen RMG; van der Schouw YT; van Gils CH; Verschuren WMM; Broekmans FJM; Borges MC; Gonçalves Soares AL; Lawlor DA; Eliassen AH; Kraft P; Sandler DP; Harlow SD; Smith JA; Santoro N; Schoemaker MJ; Swerdlow AJ; Murray A; Ruth KS; Onland-Moret NC
Hum Reprod; 2022 May; 37(5):1069-1082. PubMed ID: 35274129
[TBL] [Abstract][Full Text] [Related]
16. A Mendelian randomization study investigating the causal role of inflammation on Parkinson's disease.
Bottigliengo D; Foco L; Seibler P; Klein C; König IR; Del Greco M F
Brain; 2022 Oct; 145(10):3444-3453. PubMed ID: 35656776
[TBL] [Abstract][Full Text] [Related]
17. Assessing the association between the circulating levels of inflammatory cytokines and the risk of tuberculosis: A bidirectional two-sample mendelian randomization study.
Zhang SX; Lu ZH; Wang MT; Shen YP; Duan L; Guan SY; Chen MX; Lu Y; Yang M; Wang L; Yang GB; Lv WW; Wang JC; Zheng JX
Infect Genet Evol; 2023 Dec; 116():105524. PubMed ID: 37952650
[TBL] [Abstract][Full Text] [Related]
18. Plasma metabolites and risk of seven cancers: a two-sample Mendelian randomization study among European descendants.
Chen Y; Xie Y; Ci H; Cheng Z; Kuang Y; Li S; Wang G; Qi Y; Tang J; Liu D; Li W; Yang Y
BMC Med; 2024 Mar; 22(1):90. PubMed ID: 38433226
[TBL] [Abstract][Full Text] [Related]
19. A Mendelian randomization study on the causal association of circulating cytokines with colorectal cancer.
Kong Y; Wang X; Xu H; Liu S; Qie R
PLoS One; 2023; 18(12):e0296017. PubMed ID: 38096329
[TBL] [Abstract][Full Text] [Related]
20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
